嘉应制药: 2025年第一次临时股东大会决议公告

Meeting Overview - The shareholder meeting of Guangdong Jiaying Pharmaceutical Co., Ltd. was held on March 27, 2025, with both on-site and online voting options available [1] - A total of 154 shareholders and representatives attended the meeting, representing 63,827,999 shares, which is 12.7573% of the total voting shares [1] Voting Results - The meeting elected Mr. Li Jun Guo and Mr. Dai Ru Rong as independent directors of the seventh board, with 95.1345% and 95.1146% approval rates respectively from all attending shareholders [2] - The voting results for the independent directors showed that 90.4070% and 90.3638% of the minority investors approved their election [2] - The meeting also passed several other resolutions with minimal dissent, indicating strong shareholder support [3] Legal Compliance - The meeting was witnessed by lawyers from Hunan Qiyuan Law Firm, confirming that the procedures followed were in compliance with the Company Law and relevant regulations [4] - The legal opinion stated that the qualifications of attendees and the convening of the meeting were valid and that the voting procedures and results were legally effective [4]